Dbfetch
ID KX059431; SV 1; linear; genomic DNA; STD; HUM; 2812 BP. XX AC KX059431; XX DT 16-DEC-2016 (Rel. 131, Created) DT 16-DEC-2016 (Rel. 131, Last updated, Version 1) XX DE Homo sapiens isolate NT01349 MHC class II antigen (HLA-DRB1) gene, DE HLA-DRB1*14:53 allele, exons 2, 3 and partial cds. XX KW . XX OS Homo sapiens (human) OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. XX RN [1] RP 1-2812 RA Lazaro A.M., Masaberg C., Hou L., Hurley C.K.; RT "Novel HLA class II allele"; RL Unpublished. XX RN [2] RP 1-2812 RA Lazaro A.M., Masaberg C., Hou L., Hurley C.K.; RT ; RL Submitted (11-APR-2016) to the INSDC. RL Oncology, Georgetown University, 3970 Reservoir Rd, N.W., Washington, DC RL 20057, USA XX DR MD5; 0b2254fdc44ca9d4dad7fd1719d22b94. DR IMGT/HLA; HLA-DRB1*14:53; HLA02348. XX CC ##Assembly-Data-START## CC Assembly Method :: Assign MPS v. V1.0.0792; Gendex v. CC V.1.10.1.4631 CC Sequencing Technology :: Illumina CC ##Assembly-Data-END## XX FH Key Location/Qualifiers FH FT source 1..2812 FT /organism="Homo sapiens" FT /isolate="NT01349" FT /mol_type="genomic DNA" FT /db_xref="taxon:9606" FT gene <1..>2812 FT /gene="HLA-DRB1" FT /allele="HLA-DRB1*14:53" FT mRNA join(<1..270,2531..>2812) FT /gene="HLA-DRB1" FT /allele="HLA-DRB1*14:53" FT /product="MHC class II antigen" FT CDS join(<1..270,2531..>2812) FT /codon_start=3 FT /gene="HLA-DRB1" FT /allele="HLA-DRB1*14:53" FT /product="MHC class II antigen" FT /db_xref="GOA:A0A1L4A1C7" FT /db_xref="InterPro:IPR000353" FT /db_xref="InterPro:IPR003006" FT /db_xref="InterPro:IPR003597" FT /db_xref="InterPro:IPR007110" FT /db_xref="InterPro:IPR011162" FT /db_xref="InterPro:IPR013783" FT /db_xref="InterPro:IPR014745" FT /db_xref="InterPro:IPR036179" FT /db_xref="UniProtKB/TrEMBL:A0A1L4A1C7" FT /protein_id="API61690.1" FT /translation="RFLEYSTSECHFFNGTERVRFLDRYFYNQEEYVRFDSDVGEFRAV FT TELGRPAAEHWNSQKDFLEDRRAAVDTYCRHNYGVGESFTVQRRVHPKVTVYPSKTQPL FT QHHNLLVCSVSGFYPGSIEVRWFRNGQEEKTGVVSTGLIHNGDWTFQTLVMLETVPRSG FT EVYTCQVEHPSVTSPLTVEW" FT exon <1..270 FT /gene="HLA-DRB1" FT /allele="HLA-DRB1*14:53" FT /number=2 FT gap 271..2530 FT /estimated_length=2260 FT exon 2531..>2812 FT /gene="HLA-DRB1" FT /allele="HLA-DRB1*14:53" FT /number=3 XX SQ Sequence 2812 BP; 123 A; 140 C; 177 G; 112 T; 2260 other; cacgtttctt ggagtactct acgtctgagt gtcatttctt caatgggacg gagcgggtgc 60 ggttcctgga cagatacttc tataaccaag aggagtacgt gcgcttcgac agcgacgtgg 120 gggagttccg ggcggtgacg gagctggggc ggcctgctgc ggagcactgg aacagccaga 180 aggacttcct ggaagacagg cgggccgcgg tggacaccta ctgcagacac aactacgggg 240 ttggtgagag cttcacagtg cagcggcgag nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 300 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 360 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 420 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 480 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 540 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 600 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 660 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 720 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 780 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 840 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 900 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 960 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 1020 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 1080 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 1140 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 1200 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 1260 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 1320 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 1380 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 1440 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 1500 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 1560 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 1620 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 1680 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 1740 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 1800 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 1860 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 1920 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 1980 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 2040 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 2100 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 2160 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 2220 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 2280 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 2340 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 2400 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 2460 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn 2520 nnnnnnnnnn tccatcctaa ggtgactgtg tatccttcaa agacccagcc cctgcagcac 2580 cacaacctcc tggtctgttc tgtgagtggt ttctatccag gcagcattga agtcaggtgg 2640 ttccggaatg gccaggaaga gaagactggg gtggtgtcca caggcctgat ccacaatgga 2700 gactggacct tccagaccct ggtgatgctg gaaacagttc ctcggagtgg agaggtttac 2760 acctgccaag tggagcaccc aagcgtgaca agccctctca cagtggaatg ga 2812 //